Munich Re's Mixed Scorecard: Record Profits Mask a Pricing Squeeze That Just Won't Let Up

Munich Re's Q2 profit beats estimates, but a revenue guidance cut on falling reinsurance prices sends shares down 1.64%.

The numbers coming out of Munich Re on Friday told two very different stories. On one side sat a quarterly net profit of €2.211 billion that blew past analyst expectations by a wide margin. On the other, a revenue forecast for the reinsurance division that the board felt compelled to slash from €40 billion to €38 billion for the full year, with group-wide revenue guidance trimmed to €62 billion from €64 billion.

Investors chose to focus on the latter. The shares closed Friday at €514.60, down 1.64 percent on the day, after at one point shedding nearly three percent — a decline that put the stock among the DAX's worst performers of the session. That leaves the equity down 8.47 percent since the start of the year and roughly 15.8 percent below its 52-week high of €611.40, a level reached back in August.

The July Renewal That Changed the Calculus

The culprit behind the guidance cut is the pricing environment in the company's core business. During the July renewal season — which covers contracts across North America, South America, Australia and global clients — risk-adjusted prices fell 5.5 percent while the volume of business written contracted by 9.1 percent, dropping to €2.9 billion. Terms and conditions, by contrast, held largely steady. Averaged across the three major renewal rounds since the start of the year, the price decline comes to 3.1 percent.

This is not a Munich Re-specific problem. Swiss Re has reported a similar trajectory, underscoring that the softening is industry-wide rather than a competitive misstep by the German reinsurer. CFO Andrew Buchanan had already flagged the risk in late July, telling the Börsen-Zeitung that a "reasonable" expectation of price declines at the July renewal was warranted — a warning that effectively telegraphed the guidance revision before the numbers were even published.

Profit Engine Still Running Hot

The operational picture, however, remains robust. The second-quarter net profit of €2.211 billion translated into an annualized return on equity of 25.5 percent, while the first-half figure of €3.925 billion delivered a 23.0 percent ROE. Both metrics were flattered by unusually low large-loss claims in property-casualty reinsurance and a strong investment result. The preliminary figures released at the end of July — which pointed to around €2.2 billion for the quarter — had already beaten the analyst consensus of €1.786 billion.

Segment-level data shows a more nuanced picture. In property-casualty reinsurance, the combined ratio came in at 68.9 percent for the quarter, up from 61.0 percent a year earlier but still comfortably below the 100 percent break-even threshold. Global Specialty Insurance saw its combined ratio deteriorate more sharply, rising to 88.9 percent from 77.9 percent. Both remain profitable, but the trend line is unmistakable. The ERGO subsidiary contributed €321 million in quarterly profit, well ahead of its proportional annual guidance.

Longevity Deals Offer a Counterweight

The life and health reinsurance division is providing a partial offset. During the first half, Munich Re closed what it describes as its largest-ever single longevity transaction, covering pension liabilities of €4 billion. The CSM balance in that segment grew to €16 billion, supported by solid new business generation and favorable currency effects. The strategic push into longevity continued this week: Canadian insurer Manulife announced a deal to cede €3.2 billion in long-term care reserves to Munich American Reassurance Company, a Munich Re subsidiary, with closing expected in the fourth quarter pending regulatory approval.

Analysts see this as more than a one-off. Jefferies, which reaffirmed its "Hold" rating with a €600 price target on August 3, pointed to Munich Re's continued appetite for larger life insurance transactions as evidence that longevity is becoming a strategic pillar for future growth. The DZ Bank took a more bullish stance in late July, maintaining its buy recommendation with a €625 target when the shares were trading at €506.20.

Capital Returns Continue Uninterrupted

The confirmed net profit guidance of €6.3 billion for 2026 provides some reassurance, with management stating it remains firmly on track to hit that figure. Capital returns to shareholders are also proceeding as planned. The share buyback program authorized at the annual general meeting on April 29, 2026 — covering up to €2.25 billion in shares and running until the next AGM on April 29, 2027 — remains active. Combined with the dividend, total capital returns are expected to reach €5.3 billion.

Meanwhile, the shareholder register is shifting. Asset manager Amundi reduced its stake in Munich Re from 3.16 percent to 2.97 percent, according to a voting rights notification dated August 3.

RBC Capital Markets weighed in after Friday's results with a "Sector Perform" rating and a €500 price target, suggesting the market had largely priced in the revenue adjustment while the confirmed earnings outlook provides a stabilizing floor. The stock currently sits about five percent above its 50-day moving average, having recovered from its yearly lows — though it remains well below the August peak. For investors, the equation is straightforward: a confirmed profit target and steady capital returns against a softening pricing environment in the core reinsurance franchise.